Introduction {#sec1}
============

Since December 2019, the outbreak of a new coronavirus from Wuhan, named 2019 novel coronavirus (2019-nCov), has spread rapidly across China and other countries.[@bib1], [@bib2], [@bib3], [@bib4], [@bib5] To date (18 February 2020), there have been 72,530 confirmed cases of infection with 2019-nCov. On 30 January 2020, the World Health Organization declared the 2019-nCoV outbreak a public health emergency of international concern.[@bib6] Countries around the globe have heightened their surveillance to quickly diagnose potential new cases of 2019-nCoV. Due to the increasing outbreak of 2019-nCov, the early diagnosis of patients is crucial for prompt and effective prevention and control of 2019-nCov. Nucleic acid testing is currently the reference standard for diagnosis; however, the nucleic acid kits for testing 2019-nCoV are in short supply. Moreover, some patients infected at an early stage with 2019-nCov are negative for nucleic acid detection of 2019-nCov.[@bib7] These cases prolong the time to definitive diagnosis and increase the potential spread of 2019-nCov.

Chest computed tomography (CT), especially high-resolution CT, is an important examination to detect the lung changes, density, and pattern of lung abnormalities caused by 2019-nCov disease (COVID-19). Therefore, in an effort to expedite recognition and provide a better understanding of COVID-19, the present study was undertaken to summarise the chest CT imaging and clinical features of a series of patients infected with 2019-nCov in multiple centres, and correlate the imaging findings with the clinical findings.

Materials and methods {#sec2}
=====================

Patients {#sec2.1}
--------

The protocol for this study was approved by the institutional review boards. All patients or their legally authorised representatives provided written informed consent prior to participation in the study. Ninety-three consecutive patients infected with 2019-nCov were enrolled from January 2020 to February 2020. The flowchart of enrolled patients is shown in [Fig 1](#fig1){ref-type="fig"} . Patient baseline clinical and image data were reviewed retrospectively. The inclusion criteria were patients who (a) were positive for nucleic acid detection of 2019-nCov and (b) underwent chest CT. The exclusion criteria were (a) poor images; (b) normal chest CT; and (c) lung abnormalities, such as lung cancer, tuberculosis, hypersensitivity pneumonitis, and bronchiectasis with infection.Figure 1The flowchart of enrolment of study patients.Figure 1

Clinical information {#sec2.2}
--------------------

Baseline information (gender, age \[divided into four groups: ≤20, 20--40, 40--60, and \>60 years\]); history of epidemiological exposure (travel history to or residence in Wuhan City, China, or other cities with continuous transmission of local cases in the last 14 days before symptom onset; contact with patients with fever or respiratory symptoms from Wuhan City, China, or other cities with continuous transmission of local cases in the last 14 days before symptom onset; or epidemiologically connected to 2019-nCoV infections or clustered onsets)[@bib8]; clinical symptoms (presence of fever, body temperature, cough, expectoration, fatigue, chest tightness, breathlessness, and others); and laboratory examination (C reactive protein \[CRP\], white blood cell \[WBC\], lymphocytes decreased) of all patients were recorded and evaluated. According to the latest Chinese national recommendations for diagnosis and treatment of respiratory infections caused by 2019-nCoV (the 5th edition),[@bib8] patients were classified into mild/common-type versus heavy/critical-type infections.

Imaging protocol and analysis {#sec2.3}
-----------------------------

All patients underwent chest CT using a multidetector scanner with the following parameters: display field of view (dFOV) 32 cm, 35 mA, 120 KV, 5 mm section thickness. All CT images were reconstructed with a section thickness of 1.25 mm and reviewed separately by two cardiothoracic radiologists (8 and 15 years of experience). Disagreements were resolved in consensus involving a cardiothoracic radiologist with 17 years of experience). All CT images were evaluated on lung and mediastinal windows for the following features: (1) presence of ground-glass opacity (GGO; [Fig 2](#fig2){ref-type="fig"} ), consolidation ([Fig 3](#fig3){ref-type="fig"} ); (2) presence of nodules or fibrosis; (3) number of lobes with GGO or consolidation; (4) site of the lesions: subpleural or not; (5) presence of the following signs: halo sign, reversed-halo sign, crazy-paving sign, sieve-hole sign, cavity sign, tree-in-bud sign; (6) presence of vascular dilatation, interlobular septal thickening, and bronchodilatation; (7) presence of pleural thickening, pleural effusion; and (8) presence of lymphadenectasis.Figure 2(a) Typical case of COVID-19: a 31-year-old man with common-type COVID-19. CT showed multiple areas of GGO in the bilateral lower lung lobes with vascular dilatation and the halo sign (red arrow). (b) Atypical case of COVID-19: a 22-year-old man with mild-type COVID-19 in which the CT showed a solitary GGO (red arrow).Figure 2Figure 3(a) Typical case of COVID-19: a 78-year-old man with heavy-type COVID-19. The CT examination showed multiple subpleural patchy opacities and GGO with vasodilation and consolidation (red arrow). (b) A 58-year-old man with critical-type COVID-19. CT showed diffuse patchy consolidation and a small pleural effusion (red arrow). (c) Atypical case of COVID-19: a 21-year-old woman with mild-type disease. The CT examination showed patchy consolidation under the pleura of the right lower lobe (red arrow). (d) A 57-year-old man with common-type COVID-19. CT showed patchy GGO and consolidation under the pleura of the bilateral upper lobe (red arrow).Figure 3

A subpleural lesion is defined as a lesion located no more than 1 cm from the pleural surface. GGO was defined as subtle GGOs that are seen around the small airways and vessel ([Fig 2](#fig2){ref-type="fig"}a). The halo sign was defined as the GGO around a nodule or mass ([Fig 4](#fig4){ref-type="fig"} a). The reversed-halo sign refers to the appearance of a central GGO, which is surrounded by a crescentic- or ring-shaped air-space consolidation ([Fig 5](#fig5){ref-type="fig"} a). The crazy-paving sign refers to the appearance of GGOs with superimposed inter- and intralobular septal thickening ([Fig 4](#fig4){ref-type="fig"}b). The sieve-hole sign is a patchy shadow with interlobular septal thickening and bronchodilatation in the transverse section shaped like a sieve ([Fig 5](#fig5){ref-type="fig"}b). The cavity sign is a space for gas accumulation, seen as a transparent or low-density region in a mass or nodule in the lung ([Fig 5](#fig5){ref-type="fig"}c). The tree -in-bud sign is a branching V- and Y-shaped nodule that resembles the budding branch of a tree ([Fig 5](#fig5){ref-type="fig"}d). Bronchodilatation is defined as an increased diameter of bronchus compared to the associated pulmonary artery or the bronchi of similar cross section. Vascular dilatation is defined as increased diameter of a vessel compared to a vessel of similar cross section ([Fig 4](#fig4){ref-type="fig"}c). Lymphadenectasis refers to lymph nodes with the diameters \>1.5 cm.Figure 4Typical CT signs. (a) Halo sign in a 41-year-old woman. CT showed multiple areas of patchy consolidation with the halo sign in both lungs (red arrow). (b) Crazy-paving sign: a 49-year-old male, CT showed a GGO with crazy-paving sign in the right upper lobe (red arrow). (c) Vascular dilatation in a 33-year-old man. CT showed two GGO with vascular dilatation (red arrow). (d) Bronchodilatation in a 41-year-old man. CT showed a GGO with vascular bronchodilatation (red arrow).Figure 4Figure 5Typical CT signs. (a) Reversed-halo sign in a 21-year-old woman. CT showed multiple areas of patchy consolidation and GGO with a halo sign in the right lower lobe (red arrow). (b) Sieve-hole sign in a 60-year-old man. CT showed patchy consolidation with the sieve-hole sign in the right lower lobe (red arrow). (c) Cavity sign in a 21-year-old woman. CT showed patchy consolidation with a small cavity (red arrow). (d) Tree-in-bud sign in a 19-year-old man. CT showed patchy consolidation, surrounding the micronodular formation of the tree-in-bud sign (red arrow).Figure 5

Statistical analysis {#sec2.4}
--------------------

Categorical variables were described as frequencies and percentages. Continuous, normally distributed data were described as means and standard deviations (SD), and non-parametric data were described as medians and interquartile ranges (IQRs). Differences in age and body temperature between patients with mild/common-type and heavy/critical-type COVID-19 were analysed using an independent *t-*test; and differences in gender, age distribution, history of epidemiological exposure, clinical symptoms, laboratory examination findings, and CT findings were analysed using the chi-square test. Statistical significance was defined as *p*\<0.05. The data were analysed using the Statistical Package for Social Sciences for Windows, version 20 (IBM, Armonk, NY, USA).

Results {#sec3}
=======

Three patients with normal CT examinations were excluded. Ninety-three patients (57 males) infected with 2019-nCov were enrolled in this study, and their mean age (SD) was 52.1 (18.07) years, ranging from 7 to 89 years. At admission, they suffered from different degrees of fever (mean body temperature ± SD: 38.3±0.78°C) and cough (*n=*69, 74.2%). Some patients presented with expectoration (*n=*29, 31.2%), fatigue (*n=*16, 17.2%), chest tightness (*n=*21, 22.6%), and breathlessness (*n=*12, 12.9%).

All patients showed abnormalities on chest CT, 91 out of 93 were located at the subpleura, presenting with GGO (*n=*69, 74.2%; [Fig 2](#fig2){ref-type="fig"}), consolidation (*n=*56, 60.2%; [Fig 3](#fig3){ref-type="fig"}), as well as noodles (*n=*17, 18.3%; [Fig 2](#fig2){ref-type="fig"}b), and fibrosis (*n=*15, 16.1%). Infections often involved more than two lobes (*n=*63, 67.7%). Additionally, some other signs were indicated: vascular dilatation (*n=*83, 89.2%; [Fig 4](#fig4){ref-type="fig"}), interlobular septal thickening (*n=*29, 31.2%), bronchodilatation (*n=*44, 47.3%; [Fig 4](#fig4){ref-type="fig"}d), the halo sign (*n=*75, 80.6%; [Fig 4](#fig4){ref-type="fig"}a), reversed-halo sign (*n=*14, 15.1%; [Fig 5](#fig5){ref-type="fig"}a), crazy-paving sign (*n=*34, 36.6%; [Fig 4](#fig4){ref-type="fig"}b), sieve-hole sign (*n=*12, 12.9%; [Fig 5](#fig5){ref-type="fig"}b), cavity sign (*n=*7, 7.5%; [Fig 5](#fig5){ref-type="fig"}c), and tree-in-bud sign (*n=*3, 3.2%; [Fig 5](#fig5){ref-type="fig"}d). Moreover, pleural thickening (*n=*21, 22.6%), pleural effusion (*n=*8, 8.6%; [Fig 3](#fig3){ref-type="fig"}d), lymphadenectasis (*n=*6, 6.5%) were found.

Clinical findings between mild/common-type and heavy/critical-type infections {#sec3.1}
-----------------------------------------------------------------------------

Comparison of the clinical information from patients with mild/common-type and heavy/critical-type COVID-19 is shown in [Table 1](#tbl1){ref-type="table"} . There was a significantly higher frequency of younger patients with mild/common-type than heavy/critical-type COVID-19 (*p\<*0.05). In the present study, five patients \<20 years old all suffered from mild/common-type infections. Moreover, when the patients presented with a higher body temperature, chest tightness, and breathlessness, they were more often identified to have heavy/critical-type than mild/common-type infections (*p\<*0.05).Table 1Baseline clinical data of 93 patients with COVID-19.Table 1All patientsMild or common typeHeavy or critical type*p-*ValueNumber of patients937320/Clinical baseline informationSex (M, %)57 (61.3%)43 (58.9%)14 (70%)0.367Age (M±SD; range) years52.1±18.07\
7∼8946.7±16.9\
7∼8961.8±16.24\
21∼83\<0.001Age distribution≤20 years5 (5.4%)5 (6.8%)00.00120∼40 years23 (24.7%)22 (30.1%)1 (5%)40∼60 years42 (45.2%)34 (46.6%)8 (40%)\>60 years23 (24.7%)12 (16.4%)11 (55%)Clinical symptomsFever90 (96.8%)70 (95.9%)20 (100%)1.000Body temperature[a](#tbl1fna){ref-type="table-fn"} (max±SD; range)38.3±0.78\
37.3∼40.238±0.54\
37.3∼39.138.9±0.89\
37.9∼40.2\<0.001Cough69 (74.2%)54 (74%)15 (75%)0.926Expectoration29 (31.2%)22 (30.1%)7 (35%)0.677Fatigue16 (17.2%)11 (15.1%)5 (20%)0.479Chest tightness21 (22.6%)12 (16.4%)8 (40%)0.049Breathlessness12 (12.9%)5 (6.8%)7 (35%)0.003Others18 (19.4%)13 (17.8%)5 (25%)0.688Laboratory examinationCRP[b](#tbl1fnb){ref-type="table-fn"} increase52 (55.9%)39 (53.4%)13 (65%)0.356WBC[c](#tbl1fnc){ref-type="table-fn"} abnormal30 (32.3%)23 (31.5%) 21↓7 (35%) 3↓0.767Lymphocytes decreased[d](#tbl1fnd){ref-type="table-fn"}43 (46.2%)28 (38.4%)15 (75%)0.004HEE36 (38.7%)32 (43.8%)4 (20%)0.053[^2][^3][^4][^5][^6]

On laboratory examination, it demonstrated that lymphopenia was more often detected in patients with heavy/critical-type than mild/common-type infections (*p\<*0.05).

In the present study, there was no significant difference in gender, symptoms (cough, expectoration, fatigue), and laboratory results (CRP increase, WBC abnormal) between patients with mild/common-type and heavy/critical-type infections.

CT findings between mild/common-type and heavy/critical-type infections {#sec3.2}
-----------------------------------------------------------------------

Comparison of CT findings between patients with mild/common-type and heavy/critical-type COVID-19 are shown in [Table 2](#tbl2){ref-type="table"} . Heavy/critical-type COVID-19 was associated with multiple lobe involvement and the presence of consolidation, the crazy-paving sign, interlobular septal thickening, pleural thickening, and pleural effusion (*p\<*0.05), whereas mild/common-type COVID-19 were associated with the presence of GGO, involvement of one or two lobes, and the halo sign (*p\<*0.05).Table 2Computed tomography image data of 93 patients infected with COVID-19.Table 2All patientsMild or common typeHeavy or critical type*p-*ValueNo. of patients937320/Extension\<0.001 One lobe or two lobes30 (32.3%)30 (41.1%)0 (0%) Multiple lobes63 (67.7%)43 (59.9%)20 (100%)Number One or two10 (10.8%)10 (13.7%)00.179 More83 (89.2%)63 (76.3%)20 (100%)Morphology Ground-glass opacity69 (74.2%)58 (79.5%)11 (55%)0.027 Consolidation56 (60.2%)38 (52.1%)18 (90%)0.002 Nodule17 (18.3%)16 (82.2%)1 (5%)0.159 Fibrosis15 (16.1)12 (16.4%)3 (15%)1.000Subpleural lesions91 (97.8%)71 (97.3%)20 (100%)1.000Signs Halo sign75 (80.6%)64 (87.7%)11 (55%)0.003 Reversed-halo sign14 (15.1%)9 (12.3%)5 (25%)0.293 Crazy-paving sign34 (36.6%)20 (27.4%)14 (70%)\<0.001 Sieve-hole sign12 (12.9%)8 (11%)4 (20%)0.489 Cavity sign7 (7.5%)5 (6.8%)2 (10%)1.000 Tree-in-bud sign3 (3.2%)2 (2.8%)1 (5%)1.000 Vascular dilatation83 (89.2%)63 (86.3%)20 (100%)0.179 Interlobular septal thickening29 (31.2%)16 (21.9%)13 (65%)\<0.001 Bronchodilatation44 (47.3%)33 (45.2%)11 (55%)0.437Pleural thickening21 (22.6%)12 (16.4%)9 (45%)0.016Pleural effusion8 (8.6%)3 (4.1%)5 (25%)0.002Lymphadenectasis6 (6.5%)3 (4.1%)3 (15%)0.214

Discussion {#sec4}
==========

The present study found that CT features of COVID-19 manifested as (1) multiple lesions, GGO, involved multiple segment or lobes, causing mild/common-type infection; or (2) multiple lesions presenting with consolidation affected multiple segments or lobes and it was often alongside interlobular septal thickening, causing heavy or critical infection. Furthermore, some infections involved fewer than two lobes and presented with a nodule with or without a halo sign, in patients whose condition often was described as mild or common-type infection. Amongst these patients with COVID-19, lesions of 98.8% (91/93) of patients were with a subpleural distribution, which was inconsistent with the study of Guan *et al.* [@bib9] Notably, three patients with COVID-19 had a normal baseline CT. Thus, COVID-19 cannot be excluded in patients with a normal chest CT; isolation and real-time polymerase chain reaction (PCR) to COVID-19 is required if the patient shows respiratory symptoms related to COVID-19 or has a history of epidemiological exposure.

According to the present results, the variable chest CT patterns seen in patients with COVID-19 result from the degree of severity and stage of the infection process. Initially or early-stage infection shows limited exudation of fluid in the alveolar cavity, and the alveolar wall is complete. GGO is present on CT imaging, and these patients were mainly classified as having mild or common-type infection.

Subsequently, increasing accumulation of cell-rich exudates occurs. At the same time, the alveolar septal capillaries were expanded and blood vessel permeability increased, resulting in interlobular interstitial oedema. This is seen as patchy areas of GGO with the crazy-paving sign. Moreover, vascular dilatation was present some cases. In the present study, some patients presenting with these features would be classified as having heavy or critical-type infections (*n=*14, 70%), when the crazy-paving sign is present.

With the further accumulation of exudates in the alveolar cavity and interstitial oedema, the CT images showed patchy consolidation. At this time, interlobular septal thickening and bronchodilatation, even the sieve-hole sign, are seen. Some cases showed pleural thickening and pleural effusion, which was consistent with the report of Zhu *et al.* [@bib10] Those patients were often classified as having heavy or critical-type infection with dysfunction of much of the lung parenchyma presenting with extensive patchy consolidation, leading to hypoxia and even respiratory failure; however, Chung *et al.* [@bib11] indicated that pleural effusion was absent in patients with COVID-19, which may be caused by a small sample and mild/common-type infections.

Finally, some patients with involvement of fewer than two lobes presented with nodules indicating a mild or common condition regardless of the density of GGO or consolidation due to the limited extension of the lesions.

Although chest CT could show density and patterns of lung abnormalities in patients with COVID-19, which reflected the clinical condition to some extent, these features were not specific and are findings that can be seen in other viral and atypical infections. Therefore, these features do not differentiate COVID-19 from other viral pneumonias,[@bib12] such as severe acute respiratory syndrome (SARS)[@bib13] ^,^ [@bib14] and Middle East respiratory syndrome (MERS).[@bib15]

In addition to the chest CT features, the clinical information can also reflect the extent of COVID-19 disease. In the present study, older age, higher body temperature, chest tightness, breathlessness, and lymphopenia were associated with heavy/critical COVID-19. This may enable patient triaging for early care in the intensive care unit, which may improve the prognosis.

The present study describes the CT and clinical appearances of COVID-19, which, although are not specific to COVID-19, increases awareness of the pattern of presentation of COVID-19 and guides clinical management of patients. A patient with a history of epidemiological exposure to COVID-19, or respiratory symptoms related to COVID-19, and a chest CT showing multiple and subpleural GGO with or without consolidation in bilateral lung, could screen most patients with COVID-19. Isolation of the patient is needed rapidly to prevent person-to-person transmission. Certainly, real-time PCR for COVID-19 is also needed for a definitive diagnosis. Second, some CT features, such as consolidation and multi-lobe involvement, are related to heavy/critical-type infection, which is useful for following-up after treatment.

There are some limitations of the present study. This study enrolled a relatively small sample of patients. The focus was CT imaging at admission, but the follow-up chest CT was not provided (three cases, including digital radiography, were provided as a supplementary). Follow-up chest CT in the next clinical practice for COVID-19.

In conclusion, the CT and clinical appearances of COVID-19 are variable, reflecting the severity of COVID-19 to some extent. As the number of reported cases of 2019-nCoV infection continues to increase, radiologists and clinicians will encounter patients with this infection. As a clinician, a better understanding of the CT and clinical presentation of COVID-19 is helpful to protect ourselves, to improve diagnosis and manage the disease.
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Appendix A. Supplementary data {#appsec1}
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The following are the supplementary data to this article:Figs1Case 1: A: DR image, a 29-year-old female with low-grade fever and cough showed a shadow in left upper lobe (A), and CT showed multiple GGO in bilateral upper lobes at the same day (B-D, arrow). The size of these lesions was enlarged after 5 days (E-G, arrow).Figs1 Figs2Case 2: CT image of a 46-year-old male with fever showed multiple patchy in bilateral lung lobes (A). The size of these lesions was enlarged and the density increased after 2 days (B, arrow). DR showed the low permeability in left lobe after 6 days (C, arrow).Figs2 Figs3Case 3 (CT+DR): CT image of a 76-year-old male with fever, cough and expectoration showed multiple patchy with solid components in bilateral lung lobes (A). DR images following-up (B-D).Figs3

Supplementary data to this article can be found online at [https://doi.org/10.1016/j.crad.2020.04.001](10.1016/j.crad.2020.04.001){#interref0010aa}.

[^1]: These authors contributed equally to this work.

[^2]: HEE, history of epidemiological exposure.

[^3]: Body temperature (normal value: 36.3∼37.2°C).

[^4]: CRP: C reactive protein (normal value: 0∼5 mg/l).

[^5]: WBC: white blood cell (normal value: 3.5∼9.5×10^9^).

[^6]: Lymphocytes normal value: 20∼50%.
